These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38810)

  • 21. [Effect of neuroleptics on foot-pedal self stimulation from the ventral tegmentum mesencephali in rats and its correlation with cataleptogenic action].
    Talalaenko AN; Boreĭsha IK; Zin'kovskaia LIa
    Farmakol Toksikol; 1982; 45(2):19-22. PubMed ID: 6122595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparison of the influence of the central cholinergic system on the catalepsy induced by neuroleptics or opioids.
    Kmicińska M; Herman ZS
    Acta Pol Pharm; 1986; 43(2):171-5. PubMed ID: 2877543
    [No Abstract]   [Full Text] [Related]  

  • 23. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral consequences of long-term treatment with neuroleptic drugs.
    Iversen SD; Howells RB; Hughes RP
    Adv Biochem Psychopharmacol; 1980; 24():305-13. PubMed ID: 6105782
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison between some biochemical and behavioural effects produced by neuroleptics.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of the procedure of administration in the activity of some antidepressant or disinhibiting drugs upon behavioural despair (author's transl)].
    Scotto di Tella AM; Mercier J
    J Pharmacol; 1981; 12(2):179-88. PubMed ID: 6115098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G
    Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug.
    Uchida S; Honda F; Otsuka M; Satoh Y; Mori J; Ono T; Hitomi M
    Arzneimittelforschung; 1979; 29(10):1588-94. PubMed ID: 42413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist.
    Ossowska K; Pietraszek M; Wardas J; Wolfarth S
    Pol J Pharmacol; 2004; 56(3):295-304. PubMed ID: 15215559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
    Dall'Igna OP; Tort AB; Souza DO; Lara DR
    J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
    J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
    Coward DM; Dixon AK; Urwyler S; White TG; Enz A; Karobath M; Shearman G
    J Pharmacol Exp Ther; 1990 Jan; 252(1):279-85. PubMed ID: 1967646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
    Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
    Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of mesolimbic and extrapyramidal nuclei in the motor depressant action of narcotic drugs.
    Costall B; Fortune DH; Naylor RJ
    J Pharm Pharmacol; 1978 Sep; 30(9):566-72. PubMed ID: 29096
    [No Abstract]   [Full Text] [Related]  

  • 39. Stress induced facilitation of opiate catalepsy in the rat.
    Katz RJ
    Prog Neuropsychopharmacol; 1980; 4(3):309-12. PubMed ID: 7192005
    [No Abstract]   [Full Text] [Related]  

  • 40. GABA involvement in neuroleptic-induced catalepsy.
    Worms P; Willigens MT; Lloyd KG
    J Pharm Pharmacol; 1978 Nov; 30(11):716-8. PubMed ID: 31437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.